Literature DB >> 14684181

Raptor, a binding partner of target of rapamycin.

Kazuyoshi Yonezawa1, Chiharu Tokunaga, Noriko Oshiro, Ken-ichi Yoshino.   

Abstract

The mammalian target of rapamycin (mTOR) controls cell growth in response to amino acids and growth factors, in part by regulating p70 S6 kinase alpha (p70 alpha) and eukaryotic initiation factor 4E binding protein 1 (4EBP1). Raptor (regulatory associated protein of mTOR) is a 150 kDa mTOR binding protein that is essential for TOR signaling in vivo and also binds 4EBP1 and p70alpha through their respective TOS (TOR signaling) motifs, a short conserved segment previously shown to be required for amino acid- and mTOR-dependent regulation of these substrates in vivo. Raptor appears to serve as an mTOR scaffold protein, the binding of which to the TOS motif of mTOR substrates is necessary for effective mTOR-catalyzed phosphorylation. Further understanding of regulation of the mTOR-raptor complex in response to the nutritional environment would require identification of the interplay between the mTOR-raptor complex and its upstream effectors such as the protein products of tumor suppressor gene tuberous sclerosis complexes 1 and 2, and the Ras-related small G protein Rheb.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14684181     DOI: 10.1016/j.bbrc.2003.07.018

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  Conservation, duplication, and loss of the Tor signaling pathway in the fungal kingdom.

Authors:  Cecelia A Shertz; Robert J Bastidas; Wenjun Li; Joseph Heitman; Maria E Cardenas
Journal:  BMC Genomics       Date:  2010-09-23       Impact factor: 3.969

2.  The abundance and activation of mTORC1 regulators in skeletal muscle of neonatal pigs are modulated by insulin, amino acids, and age.

Authors:  Agus Suryawan; Teresa A Davis
Journal:  J Appl Physiol (1985)       Date:  2010-08-19

3.  Ligand-based 3-D pharmacophore generation and molecular docking of mTOR kinase inhibitors.

Authors:  Karunakar Tanneeru; Lalitha Guruprasad
Journal:  J Mol Model       Date:  2011-07-30       Impact factor: 1.810

4.  Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein.

Authors:  Tatsuhiro Sato; Akio Nakashima; Lea Guo; Fuyuhiko Tamanoi
Journal:  J Biol Chem       Date:  2009-03-19       Impact factor: 5.157

5.  Priming hMSCs with a putative anti-cancer compound, myrtucommulone-a: a way to harness hMSC cytokine expression via modulating PI3K/Akt pathway?

Authors:  Banu Iskender; Kenan Izgi; Cagri Sakalar; Halit Canatan
Journal:  Tumour Biol       Date:  2015-09-03

6.  Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk.

Authors:  Meng Chen; Adrian Cassidy; Jian Gu; George L Delclos; Fan Zhen; Hushan Yang; Michelle A T Hildebrandt; Jie Lin; Yuanqing Ye; Robert M Chamberlain; Colin P Dinney; Xifeng Wu
Journal:  Carcinogenesis       Date:  2009-12       Impact factor: 4.944

7.  CNTO 530 functions as a potent EPO mimetic via unique sustained effects on bone marrow proerythroblast pools.

Authors:  Pradeep Sathyanarayana; Estelle Houde; Deborah Marshall; Amy Volk; Dorie Makropoulos; Christine Emerson; Anamika Pradeep; Peter J Bugelski; Don M Wojchowski
Journal:  Blood       Date:  2009-03-05       Impact factor: 22.113

Review 8.  Regulation of protein synthesis by amino acids in muscle of neonates.

Authors:  Agus Suryawan; Teresa A Davis
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

9.  The Arabidopsis AtRaptor genes are essential for post-embryonic plant growth.

Authors:  Garrett H Anderson; Bruce Veit; Maureen R Hanson
Journal:  BMC Biol       Date:  2005-04-21       Impact factor: 7.431

10.  mTOR direct interactions with Rheb-GTPase and raptor: sub-cellular localization using fluorescence lifetime imaging.

Authors:  Rahul B Yadav; Pierre Burgos; Anthony W Parker; Valentina Iadevaia; Christopher G Proud; Rodger A Allen; James P O'Connell; Ananya Jeshtadi; Christopher D Stubbs; Stanley W Botchway
Journal:  BMC Cell Biol       Date:  2013-01-12       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.